Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 76,214 | 71,743 | 71,028 | 64,485 | 70,505 |
| Cost of Goods | 44,365 | 44,972 | 44,537 | 42,381 | 45,276 |
| Gross Profit | 31,849 | 26,771 | 26,491 | 22,104 | 25,229 |
| Operating Expenses | 48,349 | 44,822 | 45,934 | 44,283 | 176,626 |
| Operating Income | -16,135 | -17,079 | -18,906 | -21,798 | -151,121 |
| Interest Expense | 40 | 14 | 25 | -249 | 418 |
| Other Income | 8,138 | -1,439 | 7,717 | 7,376 | 6,343 |
| Pre-tax Income | -8,037 | -18,532 | -11,214 | -14,173 | -145,196 |
| Income Tax | -1,847 | -3,838 | -2,124 | -327 | -10,862 |
| Net Income Continuous | -6,190 | -14,694 | -9,090 | -13,846 | -134,334 |
| Minority Interests | -302 | -46 | -380 | -384 | -6,185 |
| Net Income | $-5,888 | $-14,648 | $-8,710 | $-13,462 | $-128,149 |
| EPS Basic Total Ops | -0.19 | -0.48 | -0.29 | -0.45 | -4.29 |
| EPS Basic Continuous Ops | -0.20 | -0.48 | -0.30 | -0.47 | -4.51 |
| EPS Diluted Total Ops | -0.19 | -0.48 | -0.29 | -0.45 | -4.29 |
| EPS Diluted Continuous Ops | -0.20 | -0.48 | -0.30 | -0.47 | -4.51 |
| EPS Diluted Before Non-Recurring Items | -0.23 | -0.05 | -0.22 | -0.38 | N/A |
| EBITDA(a) | $-21,561 | $-2,421 | $-14,239 | $-16,319 | $-25,883 |